Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Intangibles: 2018-2024

Historic Intangibles for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $2.2 million.

  • Legend Biotech's Intangibles fell 22.91% to $2.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.1 million, marking a year-over-year decrease of 22.91%. This contributed to the annual value of $2.2 million for FY2024, which is 46.81% down from last year.
  • Legend Biotech's Intangibles amounted to $2.2 million in FY2024, which was down 46.81% from $4.1 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Intangibles ranged from a high of $6.4 million in FY2021 and a low of $2.2 million during FY2024.
  • Its 3-year average for Intangibles is $3.2 million, with a median of $3.4 million in 2022.
  • As far as peak fluctuations go, Legend Biotech's Intangibles spiked by 432.78% in 2020, and later tumbled by 46.81% in 2024.
  • Legend Biotech's Intangibles (Yearly) stood at $3.2 million in 2020, then spiked by 100.94% to $6.4 million in 2021, then crashed by 46.75% to $3.4 million in 2022, then grew by 19.13% to $4.1 million in 2023, then tumbled by 46.81% to $2.2 million in 2024.